Cancer Res Treat.  2019 Jan;51(1):402-407. 10.4143/crt.2017.579.

PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers

Affiliations
  • 1Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
  • 2Department of Hospital Pathology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
  • 3Department of Nuclear Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
  • 4Department of Radiology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
  • 5Department of Radiation Oncology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
  • 6Department of Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea. drbreast@catholic.ac.kr

Abstract

PTEN hamartoma tumor syndrome is a spectrum of disorders characterized by unique phenotypic features including multiple hamartomas caused by mutations of the tumor suppressor gene PTEN. Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome are representative diseases, and both have several common clinical features and differences. Because PTEN mutations are associated with an increased risk of malignancy including breast, thyroid, endometrial, and renal cancers, cancer surveillance is an important element of disease management. We report a germline mutation of the PTEN (c.723dupT, exon 7) identified in a young woman with a simultaneous occurrence of breast cancer, dermatofibrosarcoma protuberans, and follicular neoplasm. This case suggests that it is critical for clinicians to recognize the phenotypic features associated with these syndromes to accurately diagnose them and provide preventive care.

Keyword

Hamartoma syndrome; Breast neoplasms; Dermatofibrosarcoma protuberans

MeSH Terms

Breast
Breast Neoplasms
Dermatofibrosarcoma
Disease Management
Exons
Female
Genes, Tumor Suppressor
Germ-Line Mutation
Hamartoma
Hamartoma Syndrome, Multiple
Humans
Kidney Neoplasms
Thyroid Gland

Figure

  • Fig. 1. A 6.8-cm-sized mass arising from right breast skin. The mass reveals T2 high signal (A) and intense enhancement after contrast enhancement (B). A 9.7-cm-sized, irregular shaped left breast mass involving skin and chest wall muscle. Heterogeneous enhancement with internal cyst (arrow in A) and signal void due to macro-calcification (arrowhead in A and B) is noted. (C) Lung window image of the breast computed tomography shows well-defined, small round nodules in both lung fields. (D) Positron emission tomography image demonstrates two large masses with different fluorodeoxyglucose (FDG) avidity in the bilateral breast. Several lymph nodes with variable FDG uptake are noted in the bilateral axillary and left supraclavicular area. Small nodular uptake (arrow) is seen in the right thyroidal area.

  • Fig. 2. (A) Diffuse infiltration of small carcinoma cells in the left breast (H&E staining, ×100). (B) Poorly differentiated spindle cell tumor in the right breast (H&E staining, ×200). Immunohistochemistry showed strong positive staining for CD34 (C) and vimentin (D) in the spindle cell component (×100).

  • Fig. 3. (A) Mucosal papillomatous lesions on the upper gingiva and hard palate. (B) Multiple polys in the sigmoid colon. (C) Direct sequencing for whole exons including intron-exon boundarie of the PTEN gene. A frameshift PTEN mutation (c.723dupT [p.Glu242Terfs]) was identified in exon 7.

  • Fig. 4. (A) A well-circumscribed thyroid tissue including various sized-follicles in the lung parenchymal tissue (H&E staining, ×100). (B) Negative immunohistochemical staining for galectin-3 (×200). Capsular invasion in minimally invasive follicular carcinoma (×40) (C) and (×100) (D).


Reference

References

1. Hobert JA, Eng C. PTEN hamartoma tumor syndrome: an overview. Genet Med. 2009; 11:687–94.
Article
2. Pilarski R, Stephens JA, Noss R, Fisher JL, Prior TW. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features. J Med Genet. 2011; 48:505–12.
Article
3. Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet. 1998; 7:507–15.
Article
4. Bushby KM, Cole T, Matthews JN, Goodship JA. Centiles for adult head circumference. Arch Dis Child. 1992; 67:1286–7.
Article
5. Eng C. PTEN: one gene, many syndromes. Hum Mutat. 2003; 22:183–98.
Article
6. Yin Y, Shen WH. PTEN: a new guardian of the genome. Oncogene. 2008; 27:5443–53.
Article
7. Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet. 1999; 8:1461–72.
Article
8. Lachlan KL, Lucassen AM, Bunyan D, Temple IK. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet. 2007; 44:579–85.
Article
9. Cheng H, Yang L, Xiong J, Peng J, Ruan Q. Multiple thyroid nodules in the lung: metastasis or ectopia? Diagn Pathol. 2015; 10:61.
Article
10. Bubien V, Bonnet F, Brouste V, Hoppe S, Barouk-Simonet E, David A, et al. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet. 2013; 50:255–63.
Full Text Links
  • CRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr